In this video, Motley Fool health-care bureau chief Brenton Flynn takes a look through some recent SEC filings where investors don't often look for information, to discover some of the less-reported information on some of the biggest names in the health-care investments sector today. He discusses Abbott Labs (NYSE: ABT) and its coming spinoff AbbVie, a new indication for Questcor (NASDAQ: QCOR), a savvy sell by Dendreon (NASDAQ: DNDN), general pessimism about the economic climate from Express Scripts (NASDAQ: ESRX), and some uncertainty from MAKO Surgical (NASDAQ:MAKO) in the wake of Hurricane Sandy.
Motley Fool Returns
Stock Advisor S&P 500
Stock Advisor launched in February of 2002. Returns as of 09/25/2020.Join Stock Advisor
Cumulative Growth of a $10,000 Investment in Stock Advisor Calculated by Time-Weighted Return